Rosenfield Lab

540

Citations

13

h-index

About Our Lab

Helekar & Rosenfield Lab


Transcranial Magnetic Stimulation
Transcranial magnetic stimulation (TMS) technologies hold great promise in achieving a deeper understanding of causal mechanisms rather than of just neural correlates of brain function. Because of this and because these devices can noninvasively modulate neural activity and plasticity in a long-lasting manner they are also proving useful in drug-free neuromodulation treatment. The available TMS devices, however, can stimulate only one cerebral cortical site at a time, and are not portable because of the large size of their stimulus-delivering electromagnetic coils and the high amount of current needed to power them.

In collaboration with Henning Voss, PhD of Weill Cornell Medicine, Santosh Helekar, MD, PhD has recently developed a new portable wearable multifocal magnetic stimulation device called transcranial rotating permanent magnet stimulator (TRPMS) that depends on rapid movement of high field strength permanent magnets. The TRPMS device is a non-invasive wearable neoprene cap with microstimulators that incorporate customized hardware and software in a battery-operated stimulator console. The console is controlled by an app on a tablet or smart phone to deliver magnetic stimulation to the brain. In pilot studies in nearly 200 subjects we have determined that this device can deliver low field focal magnetic stimuli to at least 6 cortical sites without producing any adverse effects. We have observed modulation of spontaneous motor unit potential activity in thenar muscles following stimulation of their site of representation in the primary motor cortex, as well as modification of the strength of cortical functional connectivity. The multifocal stimulation capability of the device offers for the first time the possibility of modulating the activity of cortical neural networks by stimulating multiple nodes using varied spatiotemporal stimulus patterns.

 

TRPMS cap

TRPMS cap with microstimulators placed on sites corresponding to the primary motor cortex (PMC) on the left side, and the cortex surrounding the PMC, the lateral premotor cortex and supplementary motor cortex on the right side. The smartphone screen image on the right shows the Android app used to operate the device. Ongoing studies in our laboratory at present employ electrophysiological and neuroimaging approaches to measure neuromodulatory effects of TRPMS on cortical excitability and functional connectivity, and use this tool to study the neural mechanisms underlying perception and cognition. We are also developing and testing TRPMS-based therapeutic protocols in chronic ischemic stroke and stuttering.


Research News
doctor holding a tablet with a chest scan on it's screen
Personalized Treatment Strategies for Lung Cancer
Houston Methodist researchers identified a novel and innovative marker to guide Immune Checkpoint Inhibitor Therapy for Lung Cancer.
woman sitting on an examination table in a doctor's office
Trailblazing New Perspectives: Treating Gynecological Cancers
The goal of this new study was to evaluate the feasibility of a phase three, multi-center randomized clinical trial comparing the efficacy of minimally invasive surgery with that of the traditional open method approach (laparotomy) in treating epithelial ovarian cancer.
arm in blood pressure testing machine
Getting to the Heart of Hypertension Disparities
Researchers address social risk factors for high blood pressure through a national study.
Evolving Treatment Beyond Pharmaceuticals
First-of-its-Kind Study Explores Novel Prescription Digital Therapeutic
An Unusual Presentation of Glioblastoma
Andrew Lee, MD, Herb and Jean Lyman Centennial Chair in Ophthalmology, recently published one of the first-ever reported cases of progressive vision loss as the presenting manifestation of recurrent GBM with secondary LMS to the optic chiasm.
Engaging T cell Exhaustion for Solid Tumor Immunotherapies
Houston Methodist researchers investigated T cell exhaustion in murine models of prostate cancer and melanoma to explore possible advancements in immunotherapies for solid tumors.
Fighting a Deadly Duo
Investigating therapeutics to fight deadly TB/HIV coinfections.
Houston Methodist, Rice University launch groundbreaking Digital Health Institute
This initiative builds on ongoing collaborations between Houston Methodist and Rice University to transform the future of health care.
Stage I Nodal Marginal Zone Lymphoma Treatment Landscape
Houston Methodist researchers compared systemic therapy and radiation therapy in Stage I Nodal Marginal Zone Lymphoma Patients
2024 Digital Health Workshop Seed Fund Award Winners Announced
Houston Methodist researchers and their collaborators from Rice University have been awarded grants from the 2024 PATHS-UP Digital Health Workshop.
Pilot Study Offers Insight Into Alzheimer’s Research Participants Perceptions and Self-Efficacy
In a Houston Methodist study, Alzheimer’s disease research participants showed a high interest in genetic testing and provided valuable insights that can improve how test results are disclosed.
Breast Cancer Cells
Nanomedicine Makes Big Strides in the Fight Against Breast Cancer
Researchers deliver immunotherapy directly into triple-negative breast cancer tumors with nanofluidic implants, achieving tunable and sustained dosing of immunotherapeutics with high anti-tumor activity.
headshot of Constance Mobley smiling
Liver Failure Avengers Houston Methodist Researchers First in World
Under the leadership of Constance Mobley, MD, PhD, FACS, researchers have successfully performed a first-in-human miniature liver hepatocyte transplant to change a patient’s lymph nodes into ectopic miniature livers.
Predicting the Future of Cancer Treatment

Houston Methodist faculty developed a multiscale mechanistic model to further investigate the role of miR-155 in non-small cell lung cancer and predict clinical efficacy based on preclinical data.

Taking a Closer Look at West Nile Neuroimaging

A case report reviewing West Nile neuroinvasive disease imaging characteristics and the differential diagnosis of acute leukoencephalopathy highlights the usefulness of neuroimaging in WNND diagnosis in the absence of CSF markers.

Ending Organ Transplant Rejection

Studies at Houston Methodist suggest a novel strategy that may potentially eliminate or diminish transplant rejection, autoimmune diseases, and the need for immunosuppressive drugs

Location, Location, Location is Key to Pancreatic Cancer Prognosis

Molecular alterations found in pancreatic ductal adenocarcinoma samples may have potential therapeutic implications

Donate to Houston Methodist

With your support, Houston Methodist provides exceptional research, education, and care that is truly leading medicine.

Donate Now